Souhaitez-vous accéder aux communiqués récents ?

HAMILTON, Ontario, June 08, 2026 (GLOBE NEWSWIRE) -- A newly released national report is calling for urgent, coordinated action to address chronic pain among women and women Veterans, outlining a...

HAMILTON, Ontario, 08 juin 2026 (GLOBE NEWSWIRE) -- Un rapport national récemment publié appelle à une action urgente et coordonnée pour lutter contre la douleur chronique chez les femmes et les...

Clue is now first period and menstrual cycle tracker in the world to be covered by health insurance.

NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- A new survey from Progyny (Nasdaq: PGNY), a global leader in women’s health and family building solutions, found that people navigating fertility,...

Progyny announces first-of-its-kind plan that expands access to comprehensive fertility benefits with predictable costs for small employers

Freya Biosciences announces positive Phase 1 first-in-human data with FB301 for IVF-related embryo implantation failure

GATINEAU, Quebec, April 14, 2026 (GLOBE NEWSWIRE) -- The Chronic Pain Centre of Excellence for Canadian Veterans, in partnership with the Canadian Pain Society, hosted a first-of-its-kind national...

GATINEAU, Québec, 14 avr. 2026 (GLOBE NEWSWIRE) -- Le Centre d’excellence sur la douleur chronique pour les vétérans canadiens, en partenariat avec la Société canadienne de la douleur, a...

Judge gives nod to the admissibility of plaintiffs' expert testimony supporting general causation in J&J talc MDL.

NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women’s health and family building solutions, today announced that the...